The Utility of Emerging Biomarkers and Imaging for Assessment of Cardiovascular Risk

E-ISSN： 1875-6212|10|6|712-714

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.6, 2012-11, pp. : 712-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocysteine and ADMA—emerging risk factors for cardiovascular disease?

By Hedner Thomas Himmelmann Anders Hansson Lennart

Blood Pressure, Vol. 11, Iss. 4, 2002-07 ,pp. : 197-200

Informa Healthcare

Access to resources Recommend Favorite

2D-Spatially-Selective Real-Time Magnetic Resonance Imaging for the Assessment of Microvascular Function and Its Relation to the Cardiovascular Risk Profile

By Schwitter Juerg Oelhafen Markus Wyss Barbara Kozerke Sebastian Amann-Vesti Beatrice Lüscher Thomas Boesiger Peter

Journal of Cardiovascular Magnetic Resonance, Vol. 8, Iss. 5, 2006-10 ,pp. : 759-769

Informa Healthcare

Access to resources Recommend Favorite

Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk

Current Vascular Pharmacology, Vol. 5, Iss. 1, 2007-01 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Creatinine vs. Albuminuria as Biomarkers for the Estimation of Cardiovascular Risk

Current Vascular Pharmacology, Vol. 8, Iss. 5, 2010-09 ,pp. : 604-611

Bentham Science Publishers

Access to resources Recommend Favorite

Years of Able Life in Older Persons—The Role of Cardiovascular Imaging and Biomarkers: The Cardiovascular Health Study

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 4, 2015-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite